In a randomised, three-period crossover study, psychomotor performance and
memory were tested and mood assessed for 3 h after single doses of placebo
(PL), 20 mg temazepam (T20) or 30 mg temazepam (T30) were given to six heal
thy females aged 21-23. A composite measure of psychomotor speed showed a d
ose-dependent slowing (Page's L trend test: p < 0.001; sign test PL vs T20
and T30 vs T20: p < 0.05). The number of errors in the performance of tasks
was increased, significantly in the case of some measures. Explicit memory
(Buschke Selective Reminding Task) showed significant impairment of long-t
erm but not short-term memory (Page's L trend test: p < 0.05). The form of
the dose-response curve was positively accelerating, with the difference in
performance between T20 and T30 at least as great as that between PL and T
20. Visual Analogue Scales showed a decrease in a factor representing funct
ional integrity (Page's L trend test: p < 0.05; sign test (PL vs T20: p < 0
.05), but no changes in mood. These results show that 30 mg is a useful ext
ension of the dose range of temazepam, being well tolerated and that it pro
duces a substantially greater impairment of performance than 20 mg. Copyrig
ht (C) 2001 John Wiley & Sons, Ltd.